[ Price : $8.95]
Hyman, Phelps & McNamara hires former CDER Office of Immunology and Inflammation director Julie Beitz as a principal drug regulato...[ Price : $8.95]
Positive efficacy data prompts Novo Nordisk to stop a kidney outcomes trial (FLOW) that was studying the effects of Ozempic (semag...[ Price : $8.95]
Care Access says an FDA inspection cleared it of good clinical practice violations that had been alleged by Pfizer during its VALO...[ Price : $8.95]
Federal Register notice: FDA determines that certain formulations of Baxter Pharmaceuticals Cytoxan (cyclophosphamide) for injecti...[ Price : $8.95]
FDA clears a DePuy Synthes 510(k) for the TriLEAP Lower Extremity Anatomic Plating System, a modular, procedure-specific device fo...[ Price : $8.95]
FDA warns Danvers, MA-based Abiomed about Quality System, Medical Device Reporting, and other violations in its marketing of Impel...[ Price : $8.95]
FDA issues Warning Letters to two online marketers promoting unapproved glucagon-like peptide-1 receptor agonists semaglutide and ...[ Price : $8.95]
Three stakeholder organizations suggest changes to an FDA draft guidance on postmarketing approaches to obtain data on populations...